Saltar al contenido
Aperlena
Idioma:

Ireland - Laboratory reagents - Provision of Flow Cytometry Reagents, Antibodies, Platform-Specific Consumables and Single-Cell Genomics Reagents for Ongoing Research Activities

Adjudicada Adjudicación de contrato Sin fecha límite publicada
Vigilar esta licitación

El plazo de ofertas ha cerrado. Una adjudicación o una corrección de este anuncio: un email cuando el registro lo ve. Iniciar sesión

  1. Adjudicada
  2. Publicada

Descripción

This voluntary ex-ante transparency (VEAT) notice acknowledges that Trinity College Dublin proposes to put in place a contract with Becton Dickinson UK Ltd, 1030 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5TS for the provision of flow cytometry reagents, antibodies, platform-specific consumables and single-cell genomics reagents required to support ongoing research activities across the University. The requirement encompasses specialised laboratory reagents, including fluorochrome-conjugated monoclonal antibodies, staining buffers, assay kits, instrument calibration materials, and proprietary consumables associated with BD flow cytometry and BD Rhapsody single-cell genomics platforms. These products are integral to established experimental workflows across multiple research groups, including immunophenotyping, cell signalling analysis and single-cell gene expression studies. Trinity College Dublin intends to award this contract in accordance with Article 32(2)(b)(ii) of Directive 2014/24/EU, on the basis that competition is absent for technical reasons. The required reagents are defined by specific antibody clones and fluorochrome conjugations, many of which are proprietary and are embedded within validated experimental protocols. Substitution would necessitate extensive re-validation, introduce scientific risk and delay research outputs. In addition, platform-specific consumables, including BD Rhapsody cartridge and cDNA kits are required for the operation of existing instrumentation and cannot be replaced with alternative products. While certain items may be available via resellers, this does not represent a viable alternative, as it introduces additional cost without addressing technical compatibility or continuity requirements. Accordingly, the proposed approach is necessary to ensure continuity of research and represents a proportionate and compliant procurement solution. This voluntary ex-ante transparency (VEAT) notice acknowledges that Trinity College Dublin proposes to put in place a contract with Becton Dickinson UK Ltd, 1030 Eskdale Road, Winnersh Triangle, Wokingham, Berkshire RG41 5TS for the provision of flow cytometry reagents, antibodies, platform-specific consumables and single-cell genomics reagents required to support ongoing research activities across the University. The requirement encompasses specialised laboratory reagents, including fluorochrome-conjugated monoclonal antibodies, staining buffers, assay kits, instrument calibration materials, and proprietary consumables associated with BD flow cytometry and BD Rhapsody single-cell genomics platforms. These products are integral to established experimental workflows across multiple research groups, including immunophenotyping, cell signalling analysis, and single-cell gene expression studies. Trinity College Dublin intends to award this contract in accordance with Article 32(2)(b)(ii) of Directive 2014/24/EU, on the basis that competition is absent for technical reasons. The required reagents are defined by specific antibody clones and fluorochrome conjugations, many of which are proprietary, and are embedded within validated experimental protocols. Substitution would necessitate extensive re-validation, introduce scientific risk, and delay research outputs. In addition, platform-specific consumables, including BD Rhapsody cartridge and cDNA kits, are required for the operation of existing instrumentation and cannot be replaced with alternative products. While certain items may be available via resellers, this does not represent a viable alternative, as it introduces additional cost without addressing technical compatibility or continuity requirements. Accordingly, the proposed approach is necessary to ensure continuity of research and represents a proportionate and compliant procurement solution.

Fuente oficial

Fuente: TED - Tenders Electronic Daily (Publications Office of the EU)

Verifica siempre los detalles en el anuncio oficial.

Última verificación con TED - Tenders Electronic Daily (Publications Office of the EU) hace 1 mes

Ver el anuncio oficial

Más de este comprador

Perfil completo del comprador

7 licitaciones abiertas ahora mismo

Adjudicaciones recientes

Historial de cambios

Cada vez que una fuente oficial ha vuelto a publicar este anuncio con contenido distinto. Vigilamos todas las fuentes que indexamos, incluidas las copias regionales del mismo anuncio.

  1. Léelo antes de presentarte
    • Fecha de adjudicación: Adjudicado el 20 de abril de 2026
    • Objeto y criterios: Se ha ampliado la descripción. Reléela antes de presentarte.

Sigue esta licitación y te escribimos en cuanto cambie. Crear cuenta

Licitaciones similares

Contexto de mercado

Licitación abierta media · Equipos médicos y productos farmacéuticos
10.142.739 €
9.882 abiertas ahora en Europa
Historial del comprador en Aperlena
119 anuncios registrados · 84 adjudicados
210.780.816 € en contratos adjudicados

No te pierdas ninguna licitación como esta

2 anuncios nuevos de Equipos médicos y productos farmacéuticos en Irlanda en los últimos 7 días. Recibe un email cuando aparezcan anuncios nuevos. Gratis.

Crear mi alerta
Fuente

Atajos de teclado

Recorre una lista sin tocar el ratón. Los atajos no actúan mientras escribes en un campo.

j
Resultado siguiente
k
Resultado anterior
Intro
Abrir el resultado
n
Página siguiente
p
Página anterior
c
Comparar este resultado
s
Añadir este resultado a la lista corta
/
Ir al cuadro de búsqueda
?
Mostrar estos atajos
Esc
Cerrar